ctrl K

Watchlist Price Alert

Virpax Pharmaceuticals In... (VRPX)

NASDAQ: VRPX · Real-Time Price · USD

0.24

0.00 (0.76%)

At close: May 12, 2025, 12:38 PM

Virpax Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-12.08B	-15.69M	-21.85M	-12.03M	-4.2M	-3.18M	-2.63M
Interest Income	n/a	n/a	n/a	92.82	147.93	124.64	n/a
Pretax Income	-12.07B	-15.19M	-21.65M	-12.06M	-4.34M	-3.31M	-2.64M
Net Income	-12.07B	-15.19M	-21.46M	-12.15M	-4.49M	-3.43M	-2.64M
Selling & General & Admin	6.26B	7.82M	11.08M	7.19M	2.9M	2.56M	1.48M
Research & Development	5.82B	5.12M	10.76M	4.84M	1.29M	622.74K	1.14M
Other Expenses	n/a	2.75M	194.41K	62.26K	4K	n/a	n/a
Operating Expenses	12.08B	15.69M	21.85M	12.03M	4.2M	3.18M	2.63M
Interest Expense	-103.75M	n/a	n/a	92.82K	147.93K	124.64K	14.98K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	15.69M	21.85M	12.03M	4.2M	3.18M	2.63M
Income Tax Expense	n/a	n/a	-194.41K	92.82K	147.93K	124.64K	-161.14K
Shares Outstanding (Basic)	4.25M	1.17M	1.17M	1.17M	494.51K	521.51K	4.95M
Shares Outstanding (Diluted)	4.25M	1.17M	1.17M	1.17M	494.51K	521.51K	4.95M
EPS (Basic)	-2.84K	-12.97	-18.32	-10.37	-9.07	-6.58	-0.53
EPS (Diluted)	-2.84K	-12.97	-18.32	-10.37	-9.07	-6.58	-0.53
EBITDA	-12.08B	-15.19M	n/a	n/a	-4.19M	n/a	n/a
EBIT	-12.17B	-15.19M	-21.65M	-11.96M	-4.19M	-3.18M	-2.63M
Depreciation & Amortization	91.04M	500.28K	18.35M	12.03M	4.2M	3.18M	2.63M